Psilocybin vs. MDMA for PTSD: What the Research Shows

Both psilocybin and MDMA are being studied for PTSD. Here's how they compare in mechanism, efficacy, and access.

Psilocybin vs. MDMA for PTSD: What the Research Shows

Direct Answer: MDMA-assisted therapy has the strongest evidence for PTSD specifically — 67% no longer met PTSD criteria after treatment in Phase 3 trials. Psilocybin shows strong promise but has less PTSD-specific evidence. Both work through different mechanisms.

How They Differ

MDMA: Reduces fear response while increasing trust and empathy — ideal for trauma processing. Approved by FDA for breakthrough therapy designation. Psilocybin: Produces ego dissolution and mystical experience — powerful for meaning-making and perspective shift. Broader mental health applications beyond PTSD.

Ready to experience the difference for yourself?

Try Transformation Shrooomz →

FAQ

Can psilocybin and MDMA be combined for PTSD?

Some researchers are exploring this combination, but it is not yet studied in clinical trials and carries unknown risks.